What is it?
Cladribine is a medicine used by specialists to treat adults with a type of severe MS that is quickly worsening – the technical name is ‘highly active relapsing-remitting multiple sclerosis (MS)’. The medicine can help manage symptoms and reduce the risk of further problems, reducing relapses and slowing the progression of disability. It is taken by mouth, as a tablet, in two treatment courses, one year apart.
What are the benefits?
- Removes the need for patients to take drugs daily
- Removed hospital attendance requirement for intravenous infusions
- Reduces overall hospital attendances required for monitoring
Where to start?
- RightCare Progressive Neurological Conditions Toolkit
- NHS England treatment algorithm for Multiple Sclerosis Disease-modifying Therapies and Diagram
- NICE Guidance TA93
- NICE Multiple sclerosis Quality standard QS108
- MS Charities: MS Society and MS Trust
- Supplier Information
- Email: firstname.lastname@example.org
- AHSN lead: UCLPartners